Top Highlights for July 2015:
- India based Lupin acquires GAVIS for USD 880 million to Expand US Generic.
- Cipla of India grabs 51% stake in Uganda firm Quality Chemicals Ltd for USD 26 million.
- Lupin acquired 100% equity stake in Russia’s Pharmaceutical company ZAO "Biocom".
- India's Marksans Pharma buys US based Time-Cap to strengthen its presence in the US market.
- Torrent Pharma, India completed 100% acquisition of Zyg Pharma to expand derma presence in US and Europe.
- Lupin Acquires Specialty Product Portfolio of Temmler Pharma in Germany.
For more such news and updates, please join our Group "Global Life Science Business in India" on LinkedIn.
Aagami Updates:
- Aagami CEO to visit India August 9-15, along with client from New Zealand for finalizing licensing partnership(s).
- Dinesh and Michael make presentations and co-chair sessions at US-India Healthcare Summit in Minneapolis, Minnesota.